Effects of Open-Label Lisdexamfetamine Dimesylate on Self-Reported Quality of Life in Adults with ADHD

References

• . Kessler RC, Adler L, Barkley R,. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–723
   PubMed Web of Science ®Google Scholar
• . Adler LA, Goodman DW, Kollins SH,; 303 Study Group.Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2008;69(9):1364–1373
   PubMed Web of Science ®Google Scholar
• . Goodman DW. The consequences of attention-deficit/hyperactivity disorder in adults. J Psychiatr Pract. 2007;13(5):318–327
   PubMedGoogle Scholar
• . Brod M, Johnston J, Able S, Swindle R. Validation of the adult attention-deficit/hyperactivity disorder quality-of-life Scale (AAQoL): a disease-specific quality-of-life measure. Qual Life Res. 2006;15(1):117–129
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Dodson W. A clinical perspective of attention-deficit/hyperactivity disorder into adulthood. J Clin Psychiatry. 2004;65(10):1301–1313
   PubMed Web of Science ®Google Scholar
• . Landgraf JM. Monitoring quality of life in adults with ADHD: reliability and validity of a new measure. J Atten Disord. 2007;11(3):351–362
   PubMedGoogle Scholar
• . Brod M, Perwien A, Adler L, Spencer T, Johnston J. Conceptualization and assessment of quality of life for adults with attention-deficit/hyperactivity disorder. Prim Psychiatr. 2005;12(6):58–64
   Google Scholar
• . Ware JE. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA: The Health Institute, New England Medical Centre; 1994
   Google Scholar
• . DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York, NY: Guilford Press; 1998
   Google Scholar
• . Greenhill LL, Pliszka S, Dulcan MK,. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002;41( 2 suppl)26S–49S
   PubMed Web of Science ®Google Scholar
• . Vyvanse [package insert]. Wayne, PA: Shire US Inc; 2010
   Google Scholar
• . Bastiaens L. Both atomoxetine and stimulants improve quality of life in an ADHD population treated in a community clinic. Psychiatr Q. 2008;79(2):133–137
   PubMed Web of Science ®Google Scholar
• . Biederman J, Spencer TJ, Wilens TE, Weisler RH, Read SC, Tulloch SJ; SLI 381.304 Study Group. Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr. 2005;10(12 suppl 20):16–25
   PubMedGoogle Scholar
• . Spencer TJ, Landgraf JM, Adler LA, Weisler RH, Anderson CS, Youcha SH. Attention-deficit/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults: results of a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2008;69(11):1766–1776
   PubMedGoogle Scholar
• . Swanson J, Wigal S, Greenhill L,. Objective and subjective measures of the pharmacodynamic effects of Adderall® in the treatment of children with ADHD in a controlled laboratory classroom setting. Psychopharmacol Bull. 1998;34(1):55–60
   PubMedGoogle Scholar
• . Sonuga-Barke EJS, Coghill D, DeBacker M, Swanson J. Measuring methylphenidate response in attention-deficit/hyperactivity disorder: how are laboratory classroom-based measures related to parent ratings? J Child Adolesc Psychopharmacol. 2009;19(6):691–698
   PubMed Web of Science ®Google Scholar
• . Wigal T, Brams M, Gasior M, Gao J, Squires L, Giblin J; 316 Study Group. Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using the adult workplace environment design. Behav Brain Funct. 2010;6:34
   PubMed Web of Science ®Google Scholar
• . American Psychiatric Association. Attention-deficit and disruptive behavior disorders. In: Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR, Fourth Edition Text Revision. Washington, DC: American Psychiatric Association; 2000:85–93
   Google Scholar
• . Adler LA, Spencer TJ, Biederman J,. The internal consistency and validity of the attention-deficit/hyperactivity disorder rating scale (ADHD-RS) with adult ADHD prompts as assessed during a clinical treatment trial. J ADHD Relate Disord. 2009;1(1):14–24
   Google Scholar
• . Kaufman AS, Kaufman NL. KBIT-2: Kaufman Brief Intelligence Test, Second Edition. Upper Saddle River, NJ: Pearson Education, Inc; 2004
   Google Scholar
• . International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice E6(R1). http://www.ich.org/LOB/media/MEDIA482.pdf. Accessed January 19, 2010
   Google Scholar
• . Guy W. Clinical global impressions. In: ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare; Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research Branch; 1976;218–222
   Google Scholar
• . Weiss MD, Gibbins C, Goodman DW, Hodgkins PS, Landgraf JM, Faraone SV. Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2010;71(4):381–390
   PubMedGoogle Scholar
• . Cannon M, Pelham WH, Sallee FR, Palumbo DR, Bukstein O, Daviss WB. Effects of clonidine and methylphenidate on family quality of life in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009;19(5):511–517
   PubMedGoogle Scholar
• . Danckaerts M, Sonuga-Barke EJS, Banaschewski T,. The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. Eur Child Adolesc Psychiatry. 2010;19(2):83–105
   PubMed Web of Science ®Google Scholar
• . Matza LS, Johnston JA, Faries DE, Malley KG, Brod M. Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL). Qual Life Res. 2007;16(9):1511–1520
   PubMed Web of Science ®Google Scholar
• . Kooij JJS, Marije Boonstra A, Swinkels SH, Bekker EM, de Noord I, Buitelaar JK. Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients. J Atten Disord. 2008;11(4):445–458
   PubMed Web of Science ®Google Scholar
• . Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002;111(2):279–289
   PubMed Web of Science ®Google Scholar
• . Adler LA, Spencer T, Brown TE,. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial. J Clin Psychopharmacol. 2009;29(1):44–50
   PubMed Web of Science ®Google Scholar